1. Home
  2. ACXP vs PTLE Comparison

ACXP vs PTLE Comparison

Compare ACXP & PTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • PTLE
  • Stock Information
  • Founded
  • ACXP 2017
  • PTLE 2013
  • Country
  • ACXP United States
  • PTLE Singapore
  • Employees
  • ACXP N/A
  • PTLE N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • PTLE Oil Refining/Marketing
  • Sector
  • ACXP Health Care
  • PTLE Energy
  • Exchange
  • ACXP Nasdaq
  • PTLE Nasdaq
  • Market Cap
  • ACXP 6.8M
  • PTLE 8.0M
  • IPO Year
  • ACXP 2021
  • PTLE 2024
  • Fundamental
  • Price
  • ACXP $4.45
  • PTLE $0.17
  • Analyst Decision
  • ACXP Strong Buy
  • PTLE
  • Analyst Count
  • ACXP 3
  • PTLE 0
  • Target Price
  • ACXP $143.67
  • PTLE N/A
  • AVG Volume (30 Days)
  • ACXP 75.7K
  • PTLE 34.7M
  • Earning Date
  • ACXP 11-12-2025
  • PTLE 11-03-2025
  • Dividend Yield
  • ACXP N/A
  • PTLE N/A
  • EPS Growth
  • ACXP N/A
  • PTLE N/A
  • EPS
  • ACXP N/A
  • PTLE N/A
  • Revenue
  • ACXP N/A
  • PTLE $91,415,732.00
  • Revenue This Year
  • ACXP N/A
  • PTLE N/A
  • Revenue Next Year
  • ACXP N/A
  • PTLE N/A
  • P/E Ratio
  • ACXP N/A
  • PTLE N/A
  • Revenue Growth
  • ACXP N/A
  • PTLE N/A
  • 52 Week Low
  • ACXP $3.80
  • PTLE $0.14
  • 52 Week High
  • ACXP $29.40
  • PTLE $15.78
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 41.55
  • PTLE 45.26
  • Support Level
  • ACXP $4.51
  • PTLE $0.16
  • Resistance Level
  • ACXP $5.79
  • PTLE $0.20
  • Average True Range (ATR)
  • ACXP 0.44
  • PTLE 0.03
  • MACD
  • ACXP -0.09
  • PTLE -0.00
  • Stochastic Oscillator
  • ACXP 24.34
  • PTLE 18.55

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

Share on Social Networks: